Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,891 public trials 2,118 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients

NCT04483284

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Department of Interventional Radiology, Zhongshan Hospital, Fudan University. Shanghai, Shanghai Municipality, China

View Trial Details

Active, not recruiting

Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.

NCT04220944

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Department of Interventional Radiology, Zhongshan Hospital, Fudan University. Shanghai, Shanghai Municipality, China

View Trial Details

Active, not recruiting

Anti-PD1-antibody and Pulsed HHI for Advanced BCC

NCT04679480

Conditions: Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +4 more
Locations: University Hospital Zurich, Clinic of Dermatology Zurich, Switzerland

View Trial Details

Active, not recruiting

Distribution of Bacteria in OME After Radiotherapy For NPC.

NCT06523933

Conditions: Carcinoma, Ear Diseases, Head and Neck Neoplasms, +16 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma

NCT05193617

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Hai Qiang Mai Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

Anesthesia and Cancer Study: Renal Cell Carcinoma

NCT04503148

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Active, not recruiting

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

NCT05013099

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations: CARTI Cancer Center Little Rock, Arkansas, United States

City of Hope Duarte, California, United States

Providence Saint John's Cancer Institute Santa Monica, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

View all 16 locations

View Trial Details

Active, not recruiting

Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma

NCT05389527

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Zhongshan hospital Shanghai, Shanghai Municipality, China

Eastern Hepatobiliary Surgery Hospital Shanghai, Shanghai Municipality, China

Ruijin Hospital Shanghai, Shanghai Municipality, China

The first affiliated hospital, Yat-sen university Guangzhou, China

View Trial Details

Active, not recruiting

Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients

NCT01171300

Conditions: Adenocarcinoma, Carcinoma, Colorectal Neoplasms, +12 more
Locations: University Hospitals Gasthuisberg Leuven, Vlaams-Brabant, Belgium

View Trial Details

Active, not recruiting

Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity

NCT03784066

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: UZ Leuven Leuven, Belgium

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions